Anti-BCL9L 抗体 (ab113110)
Key features and details
- Rabbit polyclonal to BCL9L
- Suitable for: ICC, WB
- Reacts with: Human
- Isotype: IgG
製品の概要
-
製品名
Anti-BCL9L antibody
BCL9L 一次抗体 製品一覧 -
製品の詳細
Rabbit polyclonal to BCL9L -
由来種
Rabbit -
特異性
ab113110 is predicted to not cross-react with other BCL family members. At least four isoforms of BCL9L are known to exist; ab113110 will detect all four. -
アプリケーション
適用あり: ICC, WBmore details -
種交差性
交差種: Human
交差が予測される動物種: Mouse, Rat -
免疫原
Synthetic peptide containing a 20 amino acid sequence from the N terminal region of Human BCL9L (NP_872363).
-
ポジティブ・コントロール
- HeLa whole cell lysate (ab150035).
-
特記事項
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at 4°C (stable for up to 12 months). -
バッファー
pH: 7.2
Preservative: 0.02% Sodium azide
Constituent: 99.98% PBS -
Concentration information loading...
-
精製度
Immunogen affinity purified -
特記事項(精製)
ab113110 is purified by affinity chromatography via a peptide column. -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG
関連製品
-
Compatible Secondaries
-
Isotype control
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab113110の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
ICC |
Use a concentration of 10 µg/ml.
|
|
WB | (1) |
Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 157 kDa.
|
特記事項 |
---|
ICC
Use a concentration of 10 µg/ml. |
WB
Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 157 kDa. |
ターゲット情報
-
機能
Transcriptional regulator that acts as an activator. Promotes beta-catenin transcriptional activity. Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1. -
組織特異性
Expressed in breast, ductal and invasive ductal carcinomas of the breast, sporadic colorectal adenomas and carcinomas (at protein level). Expressed in fetal brain. Expressed in lung, amygdala, eye, prostate, pancreatic and prostate cancers, head and neck tumors and embryonal tumor. -
配列類似性
Belongs to the BCL9 family. -
ドメイン
Tne C-terminal domain is important for its transactivation activity. -
細胞内局在
Nucleus. - Information by UniProt
-
参照データベース
- Entrez Gene: 283149 Human
- Entrez Gene: 80288 Mouse
- Entrez Gene: 300673 Rat
- Omim: 609004 Human
- SwissProt: Q86UU0 Human
- SwissProt: Q67FY2 Mouse
- Unigene: 414740 Human
- Unigene: 370270 Mouse
-
別名
- B-cell CLL antibody
- B-cell CLL/lymphoma 9-like protein antibody
- B-cell lymphoma 9-like protein antibody
see all
画像
-
All lanes : Anti-BCL9L antibody (ab113110) at 1 µg/ml
Lane 1 : Wild-type A549 cell lysate at 20 µg
Lane 2 : BCL9L knockout A549 cell lysate at 30 µg
Lane 3 : HeLa cell lysate at 20 µg
Lane 4 : HEK-293 cell lysate at 20 µg
Performed under reducing conditions.
Predicted band size: 157 kDa
Observed band size: 190 kDa why is the actual band size different from the predicted?Western blot: Anti-BCL9L antibody (ab113110) staining at 1 ug/ml, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab113110 was shown to bind specifically to BCL9L. A band was observed at 190 kDa in wild-type A549 cell lysates with no signal observed at this size in BCL9L knockout cell line. To generate this image, wild-type and BCL9L knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
-
All lanes : Anti-BCL9L antibody (ab113110) at 1 µg/ml
Lane 1 : HeLa cell lysate
Lane 2 : HeLa cell lysate with Blocking peptide
Predicted band size: 157 kDa -
Immunocytochemistry of Bcl9L in HeLa cells with ab113110 at 10 ug/mL.
プロトコール
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (2)
ab113110 は 2 報の論文で使用されています。
- Tao B et al. Matrix stiffness promotes glioma cell stemness by activating BCL9L/Wnt/ß-catenin signaling. Aging (Albany NY) 13:5284-5296 (2021). PubMed: 33535177
- Huge N et al. Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma. Hepatol Int 14:373-384 (2020). PubMed: 31440992